Narrow Therapeutic Index Drugs: Stricter Bioequivalence Requirements Explained
4
Dec
Gregory Sterling
13
Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada regulate generics like warfarin, levothyroxine, and digoxin - and why these rules matter.